Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Faraggi

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|October 9, 2002
Estimation of the area under the ROC curveDavid Faraggi, Benjamin Reiser
Biometrical Journal. Biometrische Zeitschrift|November 11, 2006
Comparing the areas under two correlated ROC curves: parametric and non-parametric approachesKaty Molodianovitch, David Faraggi, Benjamin Reiser
Biometrical Journal. Biometrische Zeitschrift|September 16, 2005
Estimation of the Youden Index and its associated cutoff pointRonen Fluss, David Faraggi, Benjamin Reiser
Statistics in Medicine|October 19, 2004
Adjusting the generalized ROC curve for covariatesEnrique F Schisterman, David Faraggi, Benjamin Reiser
Statistics in Medicine|December 14, 2005
ROC analysis for markers with mass at zeroEnrique F Schisterman, Benjamin Reiser, David Faraggi
Statistics in Medicine|July 23, 2003
ROC curve analysis for biomarkers based on pooled assessmentsDavid Faraggi, Benjamin Reiser, Enrique F Schisterman
Biometrical Journal. Biometrische Zeitschrift|July 10, 2009
Estimation of the ROC curve under verification biasRonen Fluss, Benjamin Reiser, David Faraggi, et al.
Statistics in Medicine|November 27, 2022
Generalized mean residual life models for survival data with missing censoring indicatorsWenwen Li, Huijuan Ma, David Faraggi, et al.
Statistics in Medicine|July 13, 2007
Youden Index and the optimal threshold for markers with mass at zeroEnrique F Schisterman, David Faraggi, Benjamin Reiser, et al.
Journal of Surgical Oncology|October 31, 2002
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancerRon Epelbaum, Edward Rosenblatt, Suheil Nasrallah, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|October 9, 2002
Estimation of the area under the ROC curveDavid Faraggi, Benjamin Reiser
Biometrical Journal. Biometrische Zeitschrift|November 11, 2006
Comparing the areas under two correlated ROC curves: parametric and non-parametric approachesKaty Molodianovitch, David Faraggi, Benjamin Reiser
Biometrical Journal. Biometrische Zeitschrift|September 16, 2005
Estimation of the Youden Index and its associated cutoff pointRonen Fluss, David Faraggi, Benjamin Reiser
Statistics in Medicine|October 19, 2004
Adjusting the generalized ROC curve for covariatesEnrique F Schisterman, David Faraggi, Benjamin Reiser
Statistics in Medicine|December 14, 2005
ROC analysis for markers with mass at zeroEnrique F Schisterman, Benjamin Reiser, David Faraggi
Statistics in Medicine|July 23, 2003
ROC curve analysis for biomarkers based on pooled assessmentsDavid Faraggi, Benjamin Reiser, Enrique F Schisterman
Biometrical Journal. Biometrische Zeitschrift|July 10, 2009
Estimation of the ROC curve under verification biasRonen Fluss, Benjamin Reiser, David Faraggi, et al.
Statistics in Medicine|November 27, 2022
Generalized mean residual life models for survival data with missing censoring indicatorsWenwen Li, Huijuan Ma, David Faraggi, et al.
Statistics in Medicine|July 13, 2007
Youden Index and the optimal threshold for markers with mass at zeroEnrique F Schisterman, David Faraggi, Benjamin Reiser, et al.
Journal of Surgical Oncology|October 31, 2002
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancerRon Epelbaum, Edward Rosenblatt, Suheil Nasrallah, et al.
Pageof 3